Category:
Preclinical Research Services
CAS NO:
174819-21-7
Standard:
ChP,
Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) synthesized via catalytic hydrogenation and heterocyclic coupling. It serves as a critical API in antiretroviral therapy. Molecular Formula: C14H9F3N2O2; CAS No.: 154598-52-6.
Contraindicated in pregnancy during the first trimester due to teratogenicity risks. Requires storage below 25°C in dry, light-resistant conditions. Strict occupational exposure limits apply during synthesis to prevent CNS toxicity.